Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Quotes

Analysis

Analyst Ratings

News

Press Releases

Twitter

Media Mentions

Ownership

Earnings

Abbott Laboratories (ABT) 37.90 0.28
Price Open:37.17Day's Range:31.37290 - 72.47000
Price Close:37.4852wk Range:31.37290 - 72.47000
Price Day Change:0.28Volume:5,429,898
Price % Change:0.75Market Cap:58.863B
Bid:37.53000PE Ratio:11.42
Ask:37.90000EPS Diluted:3.281
Trade ABT NOW!

The Latest On ABT

Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent 5/21/13 8:03am
UPDATE: Goldman Sachs Upgrades Abbott Laboratories; Growth Is Poised To Accelerate 5/20/13 10:47am
Benzinga's Top Upgrades 5/20/13 8:28am
A Peek Into The Market Before The Trading Starts 5/20/13 7:34am
S&P Highlights Biotech ETFs 5/10/13 7:39am
Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Lowest PEG Ratio 5/8/13 4:51am
Illumina and Other Bargain Biotech Stocks Worth a Look Now 5/1/13 12:57pm
S&P Likes The Biggest Dividend ETF 4/19/13 12:39pm
UPDATE: Jefferies Raises PT on Abbott Laboratories on In-Line Q1'13 Results, Strong Outlook 4/19/13 10:14am
Abbott Announces FDA Approval and U.S. Launch of the TECNIS Toric Intraocular Lens for Cataract Patients 4/18/13 8:04am
Abbott Laboratories Gets Dose of Market Success on Healthy Earnings, Diagnoses Strong Guidance 4/17/13 12:54pm
UPDATE: Abbott Q1 Earnings Reflect AbbVie Separation 4/17/13 9:17am
more
Press Releases
Abbott to Present at Deutsche Bank 38th Annual Health Care Conference 5/22/13 Newswire
Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent 5/21/13 Newswire
Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes 5/9/13 Newswire
Abbott to Present at UBS Global Healthcare Conference 5/8/13 Newswire
Abbott Announces FDA Approval and U.S. Launch of the TECNIS® Toric Intraocular Lens for Cataract Patients 4/18/13 Newswire
Abbott Reports First-Quarter 2013 Results 4/17/13 Newswire
Abbott Introduces Next Generation Laboratory Automation Solution to Help Meet Increased Testing Demand 4/16/13 Newswire
Abbott Initiates Voluntary Recall of FreeStyle InsuLinx® Blood Glucose Meters in the United States 4/15/13 Newswire
Abbott Hosts Conference Call for First-Quarter Earnings 4/1/13 Newswire
New Abbott Test Can Help Doctors Detect the Presence of Two Important Health Issues 3/28/13 Newswire
FDA Advisory Committee Votes Favorably on Abbott's Minimally Invasive MitraClip® Device for Patients with Significant Mitral Regurgitation Who Are Too High Risk for Surgery 3/20/13 Newswire
New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold 3/11/13 Newswire

Get the latest ABT stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Abbott Laboratories stock price.

Partner Headlines
Drug Doesn't Work? AbbVie Merely Raises the Price 5/24/13
CE Mark for Abbott's Xience Xpedition 48 - Analyst Blog 5/22/13
The New Diet Pill Players: Arena and Vivus 5/8/13
Amgen Chased By The Bubble 5/8/13
Covidien Provides 2013 Outlook - Analyst Blog 5/6/13
Zoetis Beats, Pfizer Misses In Dual Q1 Reports 4/30/13
It Gets A Little Harder From Here For Covidien 4/29/13
Arthritis Drug Boosts AbbVie 4/26/13
Earnings Beat for ABAX, Sluggish Overall - Analyst Blog 4/26/13
AbbVie Beats Q1 Estimates As Rival Pfizer Takes Hit 4/26/13
AbbVie: More Thank a One-Trick Pony? 4/24/13
Abbott - Epizyme Collaborate - Analyst Blog 4/23/13